RMD-1601

N/A

Report date: 2024/01/19 09:55:38

Base Information

Drug NameRMD-1601
Drug Alias NameRMD-1601
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRemedium Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesRemedium Bio Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A